Back to Search
Start Over
Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR
- Source :
- Prog Urol, Progrès en Urologie, Progrès en Urologie, Elsevier Masson, 2018, 28 (3), pp.146--155. ⟨10.1016/j.purol.2017.12.004⟩, Progrès en Urologie, 2018, 28 (3), pp.146--155. ⟨10.1016/j.purol.2017.12.004⟩
- Publication Year :
- 2017
-
Abstract
- Summary Background Partial nephrectomy (PN) is recommended as first-line treatment for cT1 stage kidney tumors because of a better renal function and probably a better overall survival than radical nephrectomy (RN). For larger tumors, PN has a controversial position due to lack of evidence showing good cancer control. The aim of this study was to compare the results of PN and RN in cT2a stage on overall survival and oncological results. Method A retrospective international multicenter study was conducted in the frame of the French kidney cancer research network (UroCCR). We considered all patients aged ≥ 18 years who underwent surgical treatment for localized renal cell carcinoma (RCC) stage cT2a (7.1–10 cm) between 2000 and 2014. Cox and Fine-Gray models were performed to analyze overall survival (OS), cancer specific survival (CSS) and cancer-free survival (CFS). Comparison between PN and RN was realized after an adjustment by propensity score considering predefined confounding factors: age, sex, tumor size, pT stage of the TNM classification, histological type, ISUP grade, ASA score. Results A total of 267 patients were included. OS at 3 and 5 years was 93.6% and 78.7% after PN and 88.0% and 76.2% after RN, respectively. CSS at 3 and 5 years was 95.4% and 80.2% after PN and 91.0% and 85.0% after RN. No significant difference between groups was found after propensity score adjustment for OS (HR 0.87, 95% CI: 0.37–2.05, P = 0.75), CSS (HR 0.52, 95% CI: 0.18–1.54, P = 0.24) and CFS (HR 1.02, 95% CI: 0.50–2.09, P = 0.96). Conclusion PN seems equivalent to RN for OS, CSS and CFS in cT2a stage kidney tumors. The risk of recurrence is probably more related to prognostic factors than the surgical technique. The decision to perform a PN should depend on technical feasibility rather than tumor size, both to imperative and elective situation. Level of evidence 4.
- Subjects :
- Male
medicine.medical_specialty
Biomedical Research
Urology
medicine.medical_treatment
[SDV]Life Sciences [q-bio]
International Cooperation
030232 urology & nephrology
Outcomes
Nephrectomy
Article
03 medical and health sciences
Sparing surgery
Résultats oncologiques
0302 clinical medicine
Renal cell carcinoma
medicine
Carcinoma
Partial nephrectomy
Humans
Stage (cooking)
Survival rate
Néphrectomie partielle
Carcinoma, Renal Cell
Aged
Neoplasm Staging
Retrospective Studies
Cancer du rein
business.industry
Renal Cell
Retrospective cohort study
Middle Aged
medicine.disease
Kidney Neoplasms
3. Good health
Survival Rate
Renal cancer
Treatment Outcome
Survie globale
Oncology
030220 oncology & carcinogenesis
Propensity score matching
Female
France
business
Kidney cancer
Subjects
Details
- ISSN :
- 11667087 and 24055131
- Volume :
- 28
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie
- Accession number :
- edsair.doi.dedup.....03e86ee8c110725ca21b179321e4403f
- Full Text :
- https://doi.org/10.1016/j.purol.2017.12.004⟩